Be Familiar With the Latest Monoclonal Antibody to Treat COVID-19

August 2021

Casirivimab/imdevimab will be the second monoclonal antibody authorized to treat OUTpatients with COVID-19.

This combo will be an alternative to bamlanivimab as a single-dose IV infusion. And more are in the works.

These "mabs" block the virus that causes COVID-19...SARS-CoV-2...from entering cells. And combo products may reduce the chance of developing resistant viral variants.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Administration Take Care With Meds That Should Be Given Together
COVID-19 Be Familiar With the Latest Monoclonal Antibody to Treat COVID-19
Infectious Diseases Prevent Mishaps When Dispensing Meds for C. diff Diarrhea
Topicals Help Patients Asking About Water Exposure and Topical or Transdermal Meds
Natural Medicines Listen for Patients Reporting Heart Rhythm Problems With Ginkgo
Communication Don't Shy Away From Communicating Concerns to Colleagues
Adverse Events Stay Alert for Patients Stopping Dopamine Agonists
Rheumatoid Arthritis Avoid Mix-Ups With Rheumatoid Arthritis Meds
Colon Cancer Sort Through Colon Cancer Screening Options

Be Familiar With the Latest Monoclonal Antibody to Treat COVID-19

Practical advice for a better career, with unlimited access to CE

Table of Contents